Aldosterone antagonists and outcomes in real-world older patients with heart failure and preserved ejection fraction
about
Update on heart failure with preserved ejection fraction.Beta-blockers in older patients with heart failure and preserved ejection fraction: class, dosage, and outcomes.Calcium channel blockers and outcomes in older patients with heart failure and preserved ejection fraction.Heart failure with preserved ejection fraction in the elderly: scope of the problem.Heart failure in very old adults.Interplay of parathyroid hormone and aldosterone antagonist in prevention of heart failure hospitalizations in chronic kidney disease.Spironolactone for Management of Heart Failure with Preserved Ejection Fraction: Whither to After TOPCAT?Effects of supervised exercise and dietary nitrate in older adults with controlled hypertension and/or heart failure with preserved ejection fraction.Management of Heart Failure with Preserved Ejection Fraction: Current Challenges and Future Directions.The safety of mineralocorticoid receptor antagonists (MRAs) in patients with heart failure.Second thoughts on the final rule: An analysis of baseline participant characteristics reports on ClinicalTrials.gov.Clinical Characteristics and Outcomes in the Very Elderly Patients Hospitalized for Acute Heart Failure: Importance of Pharmacologic Guideline AdherenceAssociation is not causation: treatment effects cannot be estimated from observational data in heart failure
P2860
Q33640339-9F544A6F-09F4-4B0F-86C6-130975560135Q33857564-3BA3DDC7-887E-473D-8FE0-DA42E29729F3Q37203236-84FA9295-D88A-4FEC-BB1A-53AA1B480AAAQ37633991-1204F515-E079-48AD-9426-3F67B8C48398Q38148978-D5DC7B30-4870-4E73-9F6D-68AF8144D408Q38227113-73D87768-26EB-4EBC-A818-FD8678A9AA45Q38593070-5013AA0E-212F-407C-9015-54E078C2F398Q38678366-F8B7E4E5-662F-4080-B730-F036049FA56AQ38743215-54A9FEFF-7FC3-4409-9DD0-8D9B1C647412Q38766590-5A026846-D307-4F71-972D-669C24BF9DB5Q47103652-B620A7F4-0A57-46B0-BD46-6667D5F94860Q58700387-3A10455C-EDA8-4A80-9E68-0AD928A1CE04Q58804164-922EBBCD-C50C-4557-ADAB-5FDF96CA7765
P2860
Aldosterone antagonists and outcomes in real-world older patients with heart failure and preserved ejection fraction
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Aldosterone antagonists and ou ...... nd preserved ejection fraction
@en
type
label
Aldosterone antagonists and ou ...... nd preserved ejection fraction
@en
prefLabel
Aldosterone antagonists and ou ...... nd preserved ejection fraction
@en
P2093
P2860
P50
P1433
P1476
Aldosterone antagonists and ou ...... nd preserved ejection fraction
@en
P2093
Dalane W Kitzman
Inmaculada B Aban
Kanan Patel
Thomas E Love
P2860
P356
10.1016/J.JCHF.2012.08.001
P577
2013-02-01T00:00:00Z